54557-91-4

Usage

Uses

More research would need to be conducted to fully understand the potential uses and safety measures of 4-(4-Chloro-3-methylphenyl)-4-oxobutyric acid. However, based on its chemical structure, it could potentially be used in the following applications:
Used in Chemical Synthesis:
4-(4-Chloro-3-methylphenyl)-4-oxobutyric acid is used as a building block for the synthesis of more complex organic compounds, due to its unique combination of functional groups.
Used in Pharmaceutical Industry:
4-(4-Chloro-3-methylphenyl)-4-oxobutyric acid is used as a potential precursor for the development of new drugs, as its functional groups may allow for interactions with biological targets.
Used in Material Science:
4-(4-Chloro-3-methylphenyl)-4-oxobutyric acid is used as a component in the development of new materials, such as polymers or coatings, due to its potential reactivity and stability.

InChI:InChI=1/C11H11ClO3/c1-7-6-8(2-3-9(7)12)10(13)4-5-11(14)15/h2-3,6H,4-5H2,1H3,(H,14,15)

Upstream product

• 108-30-5 succinic acid anhydride 
• 95-49-8 2-methylchlorobenzene 
• 205178-80-9 2-Bromo-1-(4-chloro-3-methylphenyl)ethan-1-one 

Downstream Products

• 91552-42-0 4-(4-chloro-3-methyl-phenyl)-butyric acid 
• 22156-45-2 4-(m-tolyl)butanoic acid 
• 54557-88-9 6-(4-chloro-3-methylphenyl)-4,5-dihydropyridazin-3(2H)-one 

Relevant academic research and scientific papers

6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER

The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) : The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) :

Design and synthesis of 2(3H)-furanone derivatives as γ-Aminobutyric acid receptor modulator

Eleven new 3-(substituted-arylidene)-5-(4-chloro-3-methyl-phenyl)-)-3H- furan-2-one were synthesized from appropriate 4-(substituted -phenyl)-4-oxo-butyric acid and isatin derivatives. Molecular docking calculations experiments were performed using EXHZ version 1.4 and Auto Dock 4.0 to identify potential g-aminobutyric acid receptor modulator among all synthesized furanones. The anticonvulsant activities of selected compounds were evaluated in mice by PTZ induced seizure method. Result indicate that all tested compounds possess anti-convulsant activity after oral administration and that the compounds 1-acetyl-3-[5-(4-bromo-phenyl) -2-oxo -furan-3-ylidene]- 1,3-dihydro-indol-2-one (C-6) and 1-acetyl-3-[5-(4-ethyl-phenyl)-2-oxo- furan-3-ylidene]-5-ethyl-1,3-dihydro-indol-2-one (C-8) possess significant anticonvulsant activity could be comparable to that of diazepam a standard.